Bifidobacterium longum subsp. infantis in experimental necrotizing enterocolitis: alterations in inflammation, innate

Mark A Underwood1, Jennifer Arriola2, Colin W Gerber2

  • 1Department of Pediatrics, University of California, Davis, Sacramento, California.

Pediatric Research
|July 8, 2014
PubMed

Insights

Probiotic Bifidobacterium longum subsp. infantis (B. infantis) reduced necrotizing enterocolitis (NEC) in a rat model. This beneficial effect was observed despite no significant changes in the cecal microbiota composition.

Area of Science:

  • Gastroenterology
  • Microbiology
  • Neonatal Research

Background:

  • Necrotizing enterocolitis (NEC) is a severe condition in premature infants.
  • Probiotics are known to reduce NEC risk.
  • The specific role of Bifidobacterium longum subsp. infantis (B. infantis) in NEC requires further investigation.

Purpose of the Study:

  • To evaluate the efficacy of B. infantis in an established rat model of NEC.
  • To assess the impact of B. infantis on inflammatory markers and gut barrier function in NEC.
  • To analyze the cecal microbiota composition following B. infantis administration.

Main Methods:

  • Rat pups were divided into dam-fed, formula-fed, and formula-fed with B. infantis groups.
  • Experimental NEC was induced via hypoxia and cold stress.
  • Ileal tissue and cecal contents were analyzed for pathology, inflammatory mediators, antimicrobial peptides, and bacterial 16S rRNA sequences.

Main Results:

  • B. infantis administration significantly decreased NEC incidence and reduced key inflammatory mediators (Il6, Cxcl1, Tnfa, Il23, iNOS).
  • Expression of antimicrobial peptides Reg3b and Reg3g was also decreased.
  • No significant differences in cecal microbiota composition were found between formula-fed and B. infantis-supplemented groups, with low Bifidobacteria detection.

Conclusions:

  • B. infantis attenuated NEC-associated inflammation in the rat model.
  • The study highlights the anti-inflammatory effects of B. infantis.
  • Significant microbial dysbiosis variability precluded determining the microbiota's precise role in experimental NEC.
Abstract

Related Concept Videos

Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from...
60
Bacterial Gastroenteritis01:18

Bacterial Gastroenteritis

Bacterial gastroenteritis, characterized by diarrhea, abdominal cramps, and vomiting, is often caused by ingestion of contaminated food or water and is frequently associated with pathogenic Escherichia coli strains. These microbes exploit two principal mechanisms to inflict disease.Shiga toxin–producing E. coli, also referred to as STEC—notably O157:H7—release Shiga toxins that target ribosomes, blocking protein synthesis. The B subunit of the toxin binds the host glycolipid...
84
Microbiota of the Large Intestine01:27

Microbiota of the Large Intestine

The large intestine hosts the most densely populated microbial ecosystem in the human body. This complex community primarily consists of anaerobic bacteria, with Bacillota (formerly Firmicutes) and Bacteroidota (formerly Bacteroidetes) as the predominant groups. The distribution of these microbes varies along different sections of the large intestine, influenced by local environmental factors such as oxygen availability and nutrient composition.The cecum, located at the beginning of the large...
94
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
62
Bacterial Flora of the Large Intestine01:29

Bacterial Flora of the Large Intestine

The gut microbiome is formed by a vast and diverse community of bacteria that colonizes our large intestine. These bacteria start residing in the gut from birth and continue diversifying throughout life, influenced by factors such as diet, lifestyle, and stress. The gut bacterial community also includes bacteria from food and those that enter the colon through the anus.
The normal gut flora of the colon plays a critical role in generating essential vitamins such as vitamins K, B5, and B7.
1.6K
Microbiota of the Stomach and Small Intestine01:27

Microbiota of the Stomach and Small Intestine

The human gastrointestinal (GI) tract is characterized by distinct physicochemical conditions that shape its microbial communities. Among these, the stomach presents a particularly challenging environment for microbial colonization due to its highly acidic pH, ranging from 1 to 3. This extreme acidity effectively limits microbial density. However, certain acid-tolerant microorganisms are capable of surviving in this niche. Notably, Helicobacter pylori can colonize the gastric mucosa,...
74